Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial

Circulation. 2022 Mar;145(9):718-720. doi: 10.1161/CIRCULATIONAHA.121.057190. Epub 2022 Feb 28.
No abstract available

Keywords: aged; anticoagulants; atrial fibrillation; edoxaban; hemorrhage; kidney; thromboembolism.

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / metabolism
  • Atrial Fibrillation / physiopathology
  • Female
  • Humans
  • Kidney Function Tests
  • Male
  • Pyridines / administration & dosage*
  • Pyridines / adverse effects
  • Thiazoles / administration & dosage*
  • Thiazoles / adverse effects

Substances

  • Pyridines
  • Thiazoles
  • edoxaban

Associated data

  • ClinicalTrials.gov/NCT02801669